Effects of histatin 5 modifications on antifungal activity and kinetics of proteolysis
Open Access
- 1 November 2019
- journal article
- research article
- Published by Wiley in Protein Science
- Vol. 29 (2) , 480-493
Abstract
Histatin 5 (Hst‐5) is an antimicrobial peptide with strong antifungal activity against Candida albicans, an opportunistic pathogen that is a common cause of oral thrush. The peptide is natively secreted by human salivary glands and shows promise as an alternative therapeutic against infections caused by C. albicans. However, Hst‐5 can be cleaved and inactivated by a family of secreted aspartic proteases (Saps) produced by C. albicans. Single‐residue substitutions can significantly affect the proteolytic resistance of Hst‐5 to Saps and its antifungal activity; the K17R substitution increases resistance to proteolysis, while the K11R substitution enhances antifungal activity. In this work, we showed that the positive effects of these two single‐residue modifications can be combined in a single peptide, K11R–K17R, with improved proteolytic resistance and antifungal activity. We also investigated the effect of additional single‐residue substitutions, with a focus on the effect of addition or removal of negatively charged residues, and found Sap‐dependent effects on degradation. Both single‐ and double‐substitutions affected the kinetics of proteolytic degradation of the intact peptide and of the fragments formed during degradation. Our results demonstrate the importance of considering proteolytic stability and not just antimicrobial activity when designing peptides for potential therapeutic applications.Keywords
Funding Information
- Burroughs Wellcome Fund (Career Award at the Scientific Interface)
- Division of Chemical, Bioengineering, Environmental and Transport Systems (1511718)
- National Institute of Allergy and Infectious Diseases (T32AI089621B)
- NIH Office of the Director (1S10OD019938)
- University of Maryland
This publication has 38 references indexed in Scilit:
- Proteolytic Cleavage of Covalently Linked Cell Wall Proteins by Candida albicans Sap9 and Sap10Eukaryotic Cell, 2011
- Protection of the oral mucosa by salivary histatin-5 against Candida albicans in an ex vivo murine model of oral infectionFEMS Yeast Research, 2010
- A Novel Immune Evasion Strategy of Candida albicans: Proteolytic Cleavage of a Salivary Antimicrobial PeptidePLOS ONE, 2009
- Kinetics of histatin proteolysis in whole saliva and the effect on bioactive domains with metal‐binding, antifungal, and wound‐healing propertiesThe FASEB Journal, 2009
- The P-113 Fragment of Histatin 5 Requires a Specific Peptide Sequence for Intracellular Translocation inCandida albicans, Which Is Independent of Cell Wall BindingAntimicrobial Agents and Chemotherapy, 2008
- Candida albicans Ssa1/2p Is the Cell Envelope Binding Protein for Human Salivary Histatin 5Journal of Biological Chemistry, 2003
- Role of α-helical conformation of histatin-5 in candidacidal activity examined by proline variantsBiochimica et Biophysica Acta (BBA) - General Subjects, 2000
- Candidacidal activity of human salivary histatin recombinant variants produced by site-directed mutagenesisGene, 1996
- Two coding change mutations in theHIS22 allele characterize the salivary histatin 3-2 protein variantHuman Mutation, 1994
- Histatins, a family of salivary histidine-rich proteins, are encoded by at least two loci (HIS1 and HIS2)Biochemical and Biophysical Research Communications, 1989